Merck KGaA Buys Bangalore 'Omics Firm | GenomeWeb

NEW YORK (GenomeWeb News) – Merck KGaA today said that it has bought Bangalore Genei (India) Private (BGIP), which makes and sells 'omics tools, through its Merck Specialties subsidiary for an undisclosed sum.

Merck acquired the Bangalore-based firm, which specializes in making and selling genomics and proteomics research products, from the Sanmar Group. The company employs over 100 people and had revenues of around INR202 million ($4.4 million) in fiscal year 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.